bicuculline has been researched along with Parkinson Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, U; Feng, JJ; Gui, ZH; Hui, YP; Li, LB; Liu, J; Niu, XL; Wu, ZH; Zhang, QJ | 1 |
| Aziz, TZ; Green, AL; Jenkinson, N; Nandi, D; Pereira, EA; Stein, JF | 1 |
| Harada, H; Okumura, T; Saitoh, K; Sakamoto, T; Takakusaki, K | 1 |
| Aziz, TZ; Jenkinson, N; Nandi, D; Stein, JF | 1 |
| Guerra, MJ; Labandeira-Garcia, JL; Parga, JA; Rodriguez-Pallares, J | 1 |
| Bartholini, G | 1 |
1 review(s) available for bicuculline and Parkinson Disease
| Article | Year |
|---|---|
Pedunculopontine stimulation from primate to patient.
Topics: Animals; Bicuculline; Biophysics; Convulsants; Deep Brain Stimulation; Disease Models, Animal; GABA-A Receptor Agonists; History, 20th Century; Humans; Macaca; Male; Muscimol; Parkinson Disease; Pedunculopontine Tegmental Nucleus | 2011 |
1 trial(s) available for bicuculline and Parkinson Disease
| Article | Year |
|---|---|
Laboratory and clinical investigations of the region of the rostral brainstem in motor control.
Topics: Animals; Antiparkinson Agents; Bicuculline; Deep Brain Stimulation; Dose-Response Relationship, Radiation; Female; GABA Antagonists; Humans; Levodopa; Macaca mulatta; Male; Motor Activity; Parkinson Disease; Parkinsonian Disorders; Pedunculopontine Tegmental Nucleus; Retrospective Studies | 2006 |
4 other study(ies) available for bicuculline and Parkinson Disease
| Article | Year |
|---|---|
The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's disease.
Topics: Action Potentials; Analysis of Variance; Animals; Bicuculline; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; GABA-A Receptor Antagonists; Indoles; Male; Oxidopamine; Parkinson Disease; Piperidines; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT3; Serotonin Agents; Statistics, Nonparametric; Substantia Nigra; Tropisetron; Tyrosine 3-Monooxygenase | 2011 |
Evidence for a role of basal ganglia in the regulation of rapid eye movement sleep by electrical and chemical stimulation for the pedunculopontine tegmental nucleus and the substantia nigra pars reticulata in decerebrate cats.
Topics: Animals; Basal Ganglia; Bicuculline; Cats; Decerebrate State; Electric Stimulation; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Muscimol; Muscle Tonus; Parkinson Disease; Pedunculopontine Tegmental Nucleus; Sleep, REM; Stimulation, Chemical; Substantia Nigra | 2004 |
Effects of GABA and GABA receptor inhibition on differentiation of mesencephalic precursors into dopaminergic neurons in vitro.
Topics: Animals; Apoptosis; Bicuculline; Cell Culture Techniques; Cell Differentiation; Cell- and Tissue-Based Therapy; Dopamine; GABA Antagonists; gamma-Aminobutyric Acid; Immunohistochemistry; Mesencephalon; Microscopy, Confocal; Neuroglia; Neurons; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, GABA; Stem Cells | 2007 |
[Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry].
Topics: 4-Aminobutyrate Transaminase; Basal Ganglia Diseases; Bicuculline; Dopamine; Dyskinesia, Drug-Induced; Epilepsy; Extrapyramidal Tracts; gamma-Aminobutyric Acid; Humans; Huntington Disease; Levodopa; Limbic System; Neural Pathways; Neurons; Neurotransmitter Agents; Parkinson Disease; Psychopharmacology | 1979 |